Health Condition 1: E888- Other specified metabolic disorders
Conditions
Interventions
Intervention1: PolyNutriBio: Dose-1g/day
Dose of administration: Oral as capsules
Frequency : Daily
Duration: Three months
Intervention2: Polyherbal Powder: The investigational product, polyherbal po
Sponsors
Department of Health Research Ministry of Health and Family Welfare Government of India
Eligibility
Inclusion criteria
Inclusion criteria: Individuals with no conventional biomarkers for diabetes, atherosclerosis and arthritis shall be selected from the population belonging to the Thiruvananthapuram district between the age group of 18-60 years after obtaining informed consent. Anthropological data and blood samples shall be collected based on routine laboratory procedure.
Exclusion criteria
Exclusion criteria: Individuals not belonging to the specified age group, without informed consent shall be excluded from the study. Individuals with diagnosed with contagious diseases, chronic illness, cancer or chemotherapy patients shall be excluded from the study. Additionally, pregnant and lactating women shall be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is to assess the efficacy of the nutraceutical mixed polyherbal powder in managing chronic inflammatory disorders. Reductions in the symptoms indicate improvements in disease severity and control, reflecting the effectiveness of the nutraceutical intervention in mitigating chronic inflammation.Timepoint: Baseline and 30, 60, 90 and 120 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess anti-inflammatory effect after the trial periodTimepoint: baseline and 30, 60, 90 and 120 days | — |
Countries
India
Contacts
Public ContactDr Maya G Pillai
University of Kerala
Outcome results
None listed